Cargando…

Drug screening using model systems: some basics

An increasing number of laboratories that focus on model systems are considering drug screening. Executing a drug screen is complicated enough. But the path for moving initial hits towards the clinic requires a different knowledge base and even a different mindset. In this Editorial I discuss the im...

Descripción completa

Detalles Bibliográficos
Autor principal: Cagan, Ross
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117237/
https://www.ncbi.nlm.nih.gov/pubmed/27821602
http://dx.doi.org/10.1242/dmm.028159
_version_ 1782468780534792192
author Cagan, Ross
author_facet Cagan, Ross
author_sort Cagan, Ross
collection PubMed
description An increasing number of laboratories that focus on model systems are considering drug screening. Executing a drug screen is complicated enough. But the path for moving initial hits towards the clinic requires a different knowledge base and even a different mindset. In this Editorial I discuss the importance of doing some homework before you start screening. 'Lead hits', 'patentable chemical space' and 'druggability' are all concepts worth exploring when deciding which screening path to take. I discuss some of the lessons I learned that may be useful as you navigate the screening matrix.
format Online
Article
Text
id pubmed-5117237
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-51172372016-12-12 Drug screening using model systems: some basics Cagan, Ross Dis Model Mech Editorial An increasing number of laboratories that focus on model systems are considering drug screening. Executing a drug screen is complicated enough. But the path for moving initial hits towards the clinic requires a different knowledge base and even a different mindset. In this Editorial I discuss the importance of doing some homework before you start screening. 'Lead hits', 'patentable chemical space' and 'druggability' are all concepts worth exploring when deciding which screening path to take. I discuss some of the lessons I learned that may be useful as you navigate the screening matrix. The Company of Biologists Ltd 2016-11-01 /pmc/articles/PMC5117237/ /pubmed/27821602 http://dx.doi.org/10.1242/dmm.028159 Text en © 2016. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/3.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Editorial
Cagan, Ross
Drug screening using model systems: some basics
title Drug screening using model systems: some basics
title_full Drug screening using model systems: some basics
title_fullStr Drug screening using model systems: some basics
title_full_unstemmed Drug screening using model systems: some basics
title_short Drug screening using model systems: some basics
title_sort drug screening using model systems: some basics
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117237/
https://www.ncbi.nlm.nih.gov/pubmed/27821602
http://dx.doi.org/10.1242/dmm.028159
work_keys_str_mv AT caganross drugscreeningusingmodelsystemssomebasics